Vanda Pharmaceuticals (VNDA) Gross Profit (2010 - 2026)
Vanda Pharmaceuticals (VNDA) reported Gross Profit of $46.97 million for Q2 2026, down 5.8% from $49.85 million a year earlier and down 3.3% from the prior quarter.
Powered by 
Analysis
Vanda Pharmaceuticals (VNDA) Gross Profit (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Vanda Pharmaceuticals' Gross Profit came in at $202.22 million, up 5.3% year-over-year; for FY2025, it was $203.06 million, up 8.3% from FY2024.
- Gross Profit has a five-year compound annual growth rate of -2.0% (FY2020 to FY2025).
- By year, Gross Profit came in at $187.46 million in FY2024 (+5.4%), $177.84 million in FY2023 (-22.7%), $230.1 million in FY2022 (-5.3%) and $243.05 million in FY2021 (+8.1%).
- The Q2 2026 figure ranks as the lowest quarterly Gross Profit since Q1 2025.
- Year over year, Gross Profit gained in seven of the last eight quarters, with growth averaging 9.9%.
- The high point for year-over-year Gross Profit in five years was Q3 2024 (growth of 26.1%); the low point was Q3 2023 (a decline of 39.4%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $48.56 million (Q1 2026), $53.38 million (Q4 2025) and $53.3 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Vanda Pharmaceuticals | 246.71 Mn | -529.97 Mn | 65.66 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 65.66 Mn |
| Jun 30, 2026 | 46.97 Mn |
| Mar 31, 2026 | 48.56 Mn |
| Dec 31, 2025 | 53.38 Mn |
| Sep 30, 2025 | 53.30 Mn |
| Jun 30, 2025 | 49.85 Mn |
| Mar 31, 2025 | 46.52 Mn |
| Dec 31, 2024 | 50.60 Mn |
| Sep 30, 2024 | 45.10 Mn |
| Jun 30, 2024 | 47.74 Mn |
| Mar 31, 2024 | 44.02 Mn |
| Dec 31, 2023 | 41.81 Mn |
| Sep 30, 2023 | 35.75 Mn |
| Jun 30, 2023 | 42.56 Mn |
| Mar 31, 2023 | 57.72 Mn |
| Dec 31, 2022 | 58.24 Mn |
| Sep 30, 2022 | 59.00 Mn |
| Jun 30, 2022 | 58.33 Mn |
| Mar 31, 2022 | 54.53 Mn |
| Dec 31, 2021 | 61.78 Mn |
API Access
Vanda Pharmaceuticals Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=VNDA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "VNDA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=VNDA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();